Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.03B
EV5.03B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
50.2
75.2
95.5
100.1
128.9
134.2
92.2
110.4
129.1
145.1
Revenue % Chg.
0.6%
49.8%
27.0%
4.7%
28.8%
4.1%
-31.3%
19.8%
16.9%
31.4%
Cost of Revenue
28.0
41.2
49.9
51.8
53.0
54.5
47.6
51.9
65.8
68.8
Gross Profit
22.2
34.1
45.6
48.2
75.9
79.6
44.5
58.6
63.3
76.3
Gross Profit Margin
44.2%
45.3%
47.7%
48.2%
58.9%
59.3%
48.3%
53.0%
49.0%
52.6%
R&D Expenses
2.5
3.8
7.4
6.7
6.8
6.5
5.3
5.5
5.5
5.8
Selling, General, & Admin Expenses
6.2
13.8
15.1
16.9
32.1
32.7
16.4
19.2
18.5
21.7
Other Expenses
1.5
3.0
5.9
5.1
6.0
5.9
6.7
7.2
7.4
7.5
Operating Income
12.0
13.4
17.2
19.4
31.1
28.8
17.7
29.3
28.6
39.2
Operating Income Margin
23.8%
17.8%
18.0%
19.4%
24.1%
21.4%
19.2%
26.6%
22.2%
27.0%
Total Other Income/Expenses Net
1.6
0.5
-1.9
-2.0
-5.3
-0.1
-10.0
-7.9
-0.0
-0.0
Income Before Tax
13.5
13.9
15.4
17.4
25.8
28.7
7.8
21.4
28.6
39.2
Income Before Tax Margin
27.0%
18.4%
16.1%
17.4%
20.0%
21.4%
8.4%
19.4%
22.1%
27.0%
Income Tax Expense
1.9
2.1
1.5
1.9
3.1
3.7
1.4
2.9
2.6
4.5
Net Income
11.7
11.8
13.8
15.5
22.7
25.0
6.4
18.5
26.0
34.7
Net Income Margin
23.3%
15.7%
14.5%
15.5%
17.6%
18.6%
6.9%
16.7%
20.1%
23.9%
Weighted Avg. Shares Out
170.6
197.8
201.7
200.6
199.4
202.0
199.2
204.7
222.8
—
EPS
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
—
EPS % Chg.
-12.1%
-12.8%
14.6%
12.8%
47.2%
9.0%
-74.1%
181.8%
29.0%
—
Weighted Avg. Shares Out Dil
170.6
197.8
201.7
200.6
199.4
204.4
199.2
204.7
222.8
—
EPS Diluted
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.1
0.1
—
Interest Income
1.0
0.6
0.1
0.1
0.2
0.2
0.3
0.8
1.2
1.1
Interest Expense
1.0
0.6
2.5
2.7
5.9
6.7
6.2
4.3
4.2
3.8
EBIT
13.6
13.9
12.9
14.9
20.1
22.2
1.8
18.0
25.5
36.5
EBIT Margin
27.0%
18.5%
13.5%
14.9%
15.6%
16.5%
1.9%
16.3%
19.8%
25.1%
Depreciation & Amortization
1.4
2.2
4.7
5.2
6.1
13.3
7.4
7.5
12.1
3.5
EBITDA
15.0
16.1
17.6
20.1
26.2
35.4
9.2
25.4
37.6
40.0
EBITDA Margin
29.8%
21.4%
18.4%
20.1%
20.3%
26.4%
10.0%
23.0%
29.1%
27.6%